TLR7通过BTK-CRT-LRP1-Hx通路促进小鼠脑出血后血红素清除
该研究在小鼠脑出血模型中探讨TLR7激活是否通过BTK-CRT-LRP1-Hx通路促进血红素清除。低剂量咪喹莫特(TLR7激动剂)减轻血肿体积、脑水肿、血脑屏障通透性和神经功能缺损,并上调TLR7、BTK、CRT、LRP1和Hx表达;TLR7抑制剂ODN2088则下调这些表达。结论提示TLR7可能通过调控该通路促进血红素清除并减轻脑水肿。
要点
- 低剂量TLR7激动剂咪喹莫特可减轻小鼠ICH后血肿、脑水肿和神经缺损。
- TLR7激活上调BTK-CRT-LRP1-Hx通路蛋白表达,TLR7抑制剂则下调。
- TLR7可能通过促进血红素清除发挥ICH后保护作用。
核心结论
- TLR7通过调控BTK-CRT-LRP1-Hx通路在小鼠脑出血后血红素清除中起重要作用,并可能通过促进血红素清除和减轻脑水肿发挥保护效应。
研究设计与样本
- 研究采用立体定位纹状体内注射VII型胶原酶诱导小鼠ICH模型。
- 小鼠随机分为假手术组、ICH+溶媒(生理盐水)组、ICH+咪喹莫特(2.5、5、10 μg/g)组、ICH+ODN2088组、ICH+LFM-A13组、ICH+毒胡萝卜素组及ICH+ODN2088+毒胡萝卜素组。
- 咪喹莫特于ICH后6小时开始每日两次腹腔注射;ODN2088于30分钟时脑室内注射;LFM-A13或毒胡萝卜素于ICH诱导后3小时腹腔注射。
- 分析指标包括神经功能评分、认知能力、脑水肿、血脑屏障通透性、血红蛋白水平及脑内TLR7/BTK/CRT/LRP1/Hx表达。
主要发现
- 低剂量咪喹莫特显著减轻ICH后血肿体积、脑水肿、血脑屏障通透性和神经功能缺损。
- 咪喹莫特增加TLR7、BTK、CRT、LRP1和Hx的蛋白表达。
- ODN2088降低TLR7、BTK、CRT、LRP1和Hx的表达。
临床怎么用
- TLR7激动剂可能作为促进脑出血后血红素清除和减轻脑水肿的潜在治疗策略,但尚未推荐用于临床。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background and Purpose- Heme and iron are considered to be key factors responsible for secondary insults after intracerebral hemorrhage (ICH). Our previous study showed that LRP1 (low-density lipoprotein receptor-related protein-1)-Hx (hemopexin) facilitates removal of heme. The TLR7 (Toll-like receptor 7)-BTK (Bruton tyrosine kinase)-CRT (calreticulin) pathway regulates the expression of LRP1-Hx. This study is designed to clarify whether TLR7 activation facilitates heme scavenging and to establish the potential role of the BTK-CRT-LRP1-Hx signaling pathway in the pathophysiology of ICH. Methods- ICH was induced by stereotactic, intrastriatal injection of type VII collagenase. Mice received TLR7 agonist (imiquimod) via intraperitoneal injection after ICH induction. TLR7 inhibitor (ODN2088), BTK inhibitor (LFM-A13), and CRT agonist (thapsigargin) were given in different groups to further evaluate the underlying pathway. Mice were randomly divided into sham, ICH+vehicle (normal saline), ICH+Imiquimod (2.5, 5, and 10 μg/g), ICH+ODN2088, ICH+LFM-A13, ICH+thapsigargin, and ICH+ODN2088+thapsigargin. Imiquimod was administered twice daily starting at 6 hours after ICH; ODN2088 was administered by intracerebroventricular injection at 30 minutes, and LFM-A13 or thapsigargin was administered by intraperitoneal injection at 3 hours after ICH induction. Neurological scores, cognitive abilities, as well as brain edema, blood-brain barrier permeability, hemoglobin level, brain expression of TLR7/BTK/CRT/LRP1/Hx were analyzed. Results- Low dosage imiquimod significantly attenuated hematoma volume, brain edema, BBB permeability, and neurological deficits after ICH. Imiquimod also increased protein expressions of TLR7, BTK, CRT, LRP1, and Hx; ODN2088 reduced TLR7, BTK, CRT, LRP1, and Hx expressions. Conclusions- TLR7 plays an important role in heme scavenging after ICH by modulating the BTK-CRT-LRP1-Hx pathway. TLR7 may offer protective effects by promoting heme resolution and reduction of brain edema after ICH.
引用
- Wang G, Guo Z, Tong L, et al. TLR7 (Toll-Like Receptor 7) Facilitates Heme Scavenging Through the BTK (Bruton Tyrosine Kinase)-CRT (Calreticulin)-LRP1 (Low-Density Lipoprotein Receptor-Related Protein-1)-Hx (Hemopexin) Pathway in Murine Intracerebral Hemorrhage. Stroke. 2018. PMID: 30571407. doi:10.1161/STROKEAHA.118.022155
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。